Geopolitical and macroeconomic headwinds have combined to slow down growth in the climate change... (13 revisions)
Pharmaceutical company Pfizer is facing scrutiny from the US Senate finance committee over its... (16 revisions)
Antibiotic-resistant infections continue to pose a significant threat, but recent breakthroughs... (22 revisions)
On December 17, 2024, U.S. stock indexes experienced a notable pullback, with the S&P 500 down... (59 revisions)